A carregar...
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
The atypical hemolytic uremic syndrome (aHUS) in the newborn is a rare disease, with high morbidity. Eculizumab, considered a first-line drug in older children, is not approved in neonates and in children weighing less than 5 kg. We present a 5-day-old female newborn, born at 36 weeks' twin ges...
Na minha lista:
| Publicado no: | AJP Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Thieme Medical Publishers, Inc.
2021
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221835/ https://ncbi.nlm.nih.gov/pubmed/34178424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0041-1731057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|